Viome Life Sciences, based in Bellevue, WA and led by Founder and CEO Naveen Jain, focuses on longevity and preventative healthcare. The company leverages AI and algorithms to analyze gene expression data from over 600,000 samples to power at-home tests and personalized recommendations. Its product lineup includes custom-formulated supplements unique to each individual, personalized biotic blends for gut health, and oral biotic lozenges for oral microbiome health. Viome intends to deploy new capital toward research and development and retail expansion. Financially, it has raised a total of $175M to date after closing an $86.5M Series C. Investors in the most recent round include Khosla Ventures, Bold Capital, WRG Ventures and others. Viome Life Sciences is a Bellevue, WA-based systems biology company that uses biological data to help individuals improve their health. The company positions itself around systems-biology approaches to personalized health. Public reporting emphasizes its aim to translate biological insights into health-improvement offerings. Financially, Viome has been an active fundraiser, most recently securing a $54M pre-Series C convertible round. This follows a $56M Series B announced in November 2019 and brings total funding to date to over $125M. Returning and new investor participation has supported its continued operations and product development efforts.

Total raised

$141M

Funding rounds

2

Latest round

Series C

Latest activity

Aug 2023